Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1306
| Despition | FGFR2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1001 | Recombinant Human DEGA Protein (6×His Tag) (AC1001) | 50 µg | inquiry |
| ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg | inquiry |
| ACPP-1105 | Human Leptin Protein (AC1105) | 200 µg | inquiry |
| ACPP-1433 | Human Interleukin 6 (Active) Protein (AC1433) | 100 µg | inquiry |
| ACPP-1347 | Human HDL Protein (AC1347) | 10 mg | inquiry |
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1302 | Noelin Blocking Peptide (AC1302) | 250 µg | inquiry |
| ACPP-1406 | Human Recoverin Protein (AC1406) | 10 µg | inquiry |
| ACPP-1758 | Human GMFB Protein (AC1758) | 2 µg | inquiry |
| ACPP-1459 | Human Midkine Protein, His (AC1459) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.